CREB1 haplotypes and the relative reinforcing value of nicotine.
Ray
R
R
Jepson
C
C
Wileyto
P
P
Patterson
F
F
Strasser
A A
AA
Rukstalis
M
M
Perkins
K
K
Blendy
J
J
Lerman
C
C
D001245:Association Learning / Q000187:drug effects / Q000502:physiology; D016022:Case-Control Studies; D002755:Choice Behavior / Q000187:drug effects; D017362:Cyclic AMP Response Element-Binding Protein / Q000187:drug effects / Q000235:genetics*; D004311:Double-Blind Method; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D009271:Naltrexone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D020641:Polymorphism, Single Nucleotide; D017450:Receptors, Opioid, mu / Q000187:drug effects / Q000235:genetics*; D012044:Regression Analysis; D012201:Reward; D012907:Smoking / Q000235:genetics*; D014029:Tobacco Use Disorder / Q000235:genetics
C115163:CREB1 protein, human; D017362:Cyclic AMP Response Element-Binding Protein; D009292:Narcotic Antagonists; D018722:Nicotinic Agonists; C485764:OPRM1 protein, human; D017450:Receptors, Opioid, mu; D009271:Naltrexone; D009538:Nicotine